Quaranta L, et al. Effect of Ginkgo biloba on preexisting visual
field damage in normal tension glaucoma. Ophthamol 110:
359-62, 2003.
Cellini M, et al. Fatty acid use in glaucomatous optic neuropathy
treatment. Acta Ophthalmol Scand Suppl 227: 41-42, 1998.
Cho E, et al. Prospective study of dietary fat and the risk of age-related
macular degeneration. Am J Clin Nutr 73: 209-218, 2001.
Anderson DR. Review: Collaborative normal tension glaucoma study.
Curr Opin Ophthalmol 14: 86-90, 2003.
Peikert A, et al. Prophylaxis of migraine with oral magnesium: results
from a prospective, multi-center placebo-controlled and double-blind
randomized study. Cephalalgia 16: 257-263, 1996.
Drance S, et al. Risk factors for progression of visual field abnormalities
in normal-tension glaucoma. Am J Ophthalmol 131: 699-708,
2001.
Knepper PA, et al. Glycosaminoglycan stratification of the juxtacanalicular
tissue in normal and primary open-angle glaucoma. Invest Ophthalmol
37: 2414- 2425, 1996.
Ziegler D, et al. Treatment of symptomatic diabetic polyneuropathy
with the antioxidant alpha-lipoic acid: A 7 month multicenter randomized
controlled trial. Diabetes Care 22: 1296-1301, 1999.
Fennessy FM, et al. Taurine and vitamin
C modify monocyte and endothelial dysfunction in young smokers.
Circulation 107: 2003.
Roes EV, et al. Effects of oral N-acetylcysteine on plasma homocysteine
and whole blood glutathione levels in healthy, non-pregnant women.
Clin Chem Lab Med 40: 496-498, 2002.
Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary
antioxidant flavonoids
and risk of coronary heart disease: the Zutphen Elderly Study. Lancet
342: 1007-1011, 1993.
Hwa-Young K, et al. Effects of phenol-depleted and phenol-rich diets
on blood markers of oxidative stress, and urinary excretion of quercetin
and kaempferol in healthy volunteers. J Am Coll Nutr
22: 217-233, 2003.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.